FMC Corporation (NYSE:FMC) raised about $1B through asset sales and a planned $400M minority stake while redeeming $500M notes, reported Q2 EBITDA above guidance with strong free cash flow and debt reduction but cut its full‑year outlook as analysts trimmed price targets.
Previous Week Recap
- FMC Raised ~ $1B Via Diverse Deals: FMC raised ~ $1B via: selling India unit $252M, rimisoxafen licensing $200M, $114M Newark property deal, and planned $400M minority investment from Tessenderlo; redeemed $500M notes.
- FMC Q2 EBITDA Beats, Outlook Trimmed: FMC reported Q2 EBITDA above guidance despite weak sales, delivered strong free cash flow and reduced debt, but cut full-year outlook; expects growth to resume in Q4 from new products and cost cuts.
- Analysts Cut FMC Targets: Analysts cut FMC Corp price targets this week: Barclays lowered target to $11 from $13 and kept Underweight; Citigroup trimmed target to $12 from $14 and kept Neutral.
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original sources.